These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17048503)

  • 21. Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol.
    Bonechi C; Martini S; Ciani L; Lamponi S; Rebmann H; Rossi C; Ristori S
    PLoS One; 2012; 7(8):e41438. PubMed ID: 22936976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of resveratrol, a red wine polyphenol, from solutions and hydrogels via the skin.
    Hung CF; Lin YK; Huang ZR; Fang JY
    Biol Pharm Bull; 2008 May; 31(5):955-62. PubMed ID: 18451526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Submicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugs.
    Wang JJ; Sung KC; Hu OY; Yeh CH; Fang JY
    J Control Release; 2006 Oct; 115(2):140-9. PubMed ID: 16959357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nano-Resveratrol Liposome: Physicochemical Stability, In Vitro Release, and Cytotoxicity.
    Li Y; Sun K; Chen S; Zhao J; Lei Y; Geng L
    Appl Biochem Biotechnol; 2023 Oct; 195(10):5950-5965. PubMed ID: 36729296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies.
    Singh G; Pai RS
    Drug Deliv; 2015; 22(4):522-30. PubMed ID: 24512464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel cilostazol-loaded solid SNEDDS using a SPG membrane emulsification technique: Physicochemical characterization and in vivo evaluation.
    Mustapha O; Kim KS; Shafique S; Kim DS; Jin SG; Seo YG; Youn YS; Oh KT; Lee BJ; Park YJ; Yong CS; Kim JO; Choi HG
    Colloids Surf B Biointerfaces; 2017 Feb; 150():216-222. PubMed ID: 27918966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liposome co-encapsulation as a strategy for the delivery of curcumin and resveratrol.
    Huang M; Liang C; Tan C; Huang S; Ying R; Wang Y; Wang Z; Zhang Y
    Food Funct; 2019 Oct; 10(10):6447-6458. PubMed ID: 31524893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes.
    Mendes JB; Riekes MK; de Oliveira VM; Michel MD; Stulzer HK; Khalil NM; Zawadzki SF; Mainardes RM; Farago PV
    ScientificWorldJournal; 2012; 2012():542937. PubMed ID: 22666135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency of resveratrol-loaded sericin nanoparticles: Promising bionanocarriers for drug delivery.
    Suktham K; Koobkokkruad T; Wutikhun T; Surassmo S
    Int J Pharm; 2018 Feb; 537(1-2):48-56. PubMed ID: 29229512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles.
    Zu Y; Zhang Y; Wang W; Zhao X; Han X; Wang K; Ge Y
    Drug Deliv; 2016; 23(3):981-91. PubMed ID: 24918466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amphiphilic nanoparticles of resveratrol-norcantharidin to enhance the toxicity in zebrafish embryo.
    Yan D; Ni LK; Chen HL; Chen LC; Chen YH; Cheng CC
    Bioorg Med Chem Lett; 2016 Feb; 26(3):774-777. PubMed ID: 26764188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Solid Dispersion System for Improving the Oral Bioavailability of Resveratrol in Rats.
    Chang CW; Wong CY; Wu YT; Hsu MC
    Eur J Drug Metab Pharmacokinet; 2017 Apr; 42(2):239-249. PubMed ID: 27118361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
    PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol.
    Augustin MA; Sanguansri L; Lockett T
    Ann N Y Acad Sci; 2013 Jul; 1290():107-12. PubMed ID: 23855472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and in vitro-in vivo characterization of trans-resveratrol nanosuspensions.
    Dong Q; Yuan HL; Qian JJ; Zhang CY; Chen WD
    Biomed Mater Eng; 2018; 29(3):333-345. PubMed ID: 29578462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of glutaraldehyde on in vivo colon-specific release of resveratrol from biodegradable pectin-based formulation.
    Das S; Ng KY
    J Pharm Sci; 2010 Dec; 99(12):4903-16. PubMed ID: 20572052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol nanoformulations: challenges and opportunities.
    Summerlin N; Soo E; Thakur S; Qu Z; Jambhrunkar S; Popat A
    Int J Pharm; 2015 Feb; 479(2):282-90. PubMed ID: 25572692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Encapsulation of mixtures of tuna oil, tributyrin and resveratrol in a spray dried powder formulation.
    Sanguansri L; Day L; Shen Z; Fagan P; Weerakkody R; Cheng LJ; Rusli J; Augustin MA
    Food Funct; 2013 Dec; 4(12):1794-802. PubMed ID: 24121865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bifunctional viscous nanovesicles co-loaded with resveratrol and gallic acid for skin protection against microbial and oxidative injuries.
    Vitonyte J; Manca ML; Caddeo C; Valenti D; Peris JE; Usach I; Nacher A; Matos M; Gutiérrez G; Orrù G; Fernàndez-Busquets X; Fadda AM; Manconi M
    Eur J Pharm Biopharm; 2017 May; 114():278-287. PubMed ID: 28192250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.